| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | $13,7100 | -1,79% | $838,42M | $2,51M | |
| $46,4200 | -3,11% | $837,92M | $151,13K | |
| $19,7300 | -0,45% | $836,70M | $272,21K | |
EVC Entravision Communication | $8,3800 | -6,99% | $835,71M | $1,96M | |
ETON Eton Pharmaceutcials, Inc. Common Stock | $27,6250 | +0,82% | $834,09M | $331,87K | |
| $25,8350 | -3,80% | $832,22M | $189,53K | |
AMPH Amphastar Pharmaceuticals, Inc. | $18,1100 | -1,84% | $831,15M | $509,28K | |
MATW Matthews International Corp | $25,4350 | -2,55% | $828,11M | $241,07K | |
TBPH Theravance Biopharma, Inc. | $15,9100 | +2,12% | $827,94M | $334,98K | |
MPB Mid Penn Bancorp, Inc. | $31,5200 | -4,14% | $827,51M | $169,05K | |
KRO Kronos Worldwide, Inc. | $7,0700 | -2,21% | $827,23M | $177,04K | |
ADAM Adamas Trust, Inc. Common Stock | $8,7800 | -2,98% | $826,72M | $643,02K | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | $21,8900 | -0,23% | $824,89M | $22,22K | |
ROOT Root, Inc. Class A Common Stock | $52,3300 | -6,08% | $823,91M | $254,39K | |
EOI Eaton Vance Enhanced Equity Income Fund | $19,7900 | -0,75% | $823,31M | $57,25K | |
